Home/Filings/4/0000899243-19-000289
4//SEC Filing

Chan Gerald 4

Accession 0000899243-19-000289

CIK 0001492422other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:23 PM ET

Size

5.4 KB

Accession

0000899243-19-000289

Insider Transaction Report

Form 4
Period: 2019-01-01
Chan Gerald
Director
Transactions
  • Award

    Stock option (right to buy)

    2019-01-01+17,58017,580 total
    Exercise: $13.19Exp: 2028-12-31Common Stock (17,580 underlying)
Footnotes (1)
  • [F1]This option was granted on January 1, 2019 and will vest in four equal quarterly installments on April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020, subject to continued service as a director.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001636579

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:23 PM ET
Size
5.4 KB